Who we are

Support us

Career opportunities

Areas of Research

Principal Investigators

president's office
scientific director's office
newsroom
publications
events & seminars
diseases we fight
technology development
center for human cell therapy
research administration
core facilities
image gallery
search
directory
contact / directions
employee intranet
employee email
For the Children - CBRI

For the Children

CBRI's Goldfeld teams with Jolie to fight TB and AIDS
CBRI Investigator Anne Goldfeld, M.D., and actress Angelina Jolie are working together to improve the lives of people in Cambodia suffering from tuberculosis and AIDS. Recently, Goldfeld met with Jolie and actor Brad Pitt when they visited the Maddox Chivan Children's Center. more >>

For the Children

For the Children - CBRI

CBRI's Goldfeld teams with Jolie to fight TB and AIDS

Learn more >>

IDI Investigator Motomu Shimaoka, recently promoted to Assoc Prof in Anesthesiology at HMS, reports:
In a technical advance for therapeutic RNA, (clockwise from top) Dan Peer, Christopher Carman, Eun Jeong Park, Yoshiyuki Morishita, and Motomu Shimaoka devised a novel nanoscale delivery particle that deposits siRNAs in hard-to-target immune cells. The particles calmed intestinal inflammation in mice by silencing the cyclin D1 gene
more >>

MicroRNA regulates cancer stem cells
One of the biggest stories in cancer research over the past few years has been, unexpectedly, stem cells. Not embryonic stem cells, but tumor stem cells.
more >>

2007 Novartis Basic Immunology Prize
Two IDI investigators and a member of the scientific advisory board have been named as recipients of the 2007 Novartis Basic Immunology Prize.
more >>

 

© 2004 The Immune Disease Institute All rights reserved.
800 Huntington Avenue, Boston, Massachusetts, 02115

 
Harvard Medical School Affiliate
The CBR Institute for Biomedical Research

CBRI has, in order to reflect its principal research programs, taken the new name of Immune Disease Institute. To celebrate this important milestone in our history, we are creating a new web site. We look forward to sharing it with you in the fall.